All adverse outcomes were of mild or moderate severity, and no significant trends were observed on the basis of LVEF status. The most common adverse events were hypotension (33%-36.4%), arrhythmia ...

Medical device maker Abbott Laboratories is nearing a potential takeover of cancer test maker Exact Sciences Corp , Bloomberg ...

As screening guidelines evolve and GI care increasingly shifts to outpatient settings, ASCs are seeing significant growth in colonoscopy volume. Here are ten developments shaping that trend: ...

Gastrointestinal procedures continue to dominate the ASC landscape in 2025, driven by increased screening demand, younger-onset colorectal cancer and ongoing migration of cases out of hospitals. All ...

Scientists have created swallowable microsphere “pills” packed with engineered bacteria that can detect signs of gut disease, ...

Move over, colonoscopies—researchers report in ACS Sensors that they've developed a sensor made of tiny microspheres packed ...

Chinese researchers have developed a new sensor made of tiny microspheres packed with blood-sensing bacteria that detect ...

Swapping colonoscopies for swallowing a pill packed with bacteria that can read the condition of our gut could revolutionize ...

Bloomberg reports today that Abbott (NYSE: ABT) is close to a deal to acquire diagnostics developer Exact Sciences (Nasdaq:EXAS).

Your primary care provider is more than just your annual stop for routine checkups. They're also the central hub for coordinating your health care, from specialist visits to follow-up testing ...

Shannon Sharpe had just landed the job he’d spent years chasing, a dream co-hosting role with Skip Bayless on FS1, when a ...